Effects of physical activity on carbohydrate and lipid metabolism in women with abdominal obesity

• Autorzy: Kasprzak Z. , Pilaczynska-Szczesniak L.
• Języki publikacji: EN

Abstrakty

EN

Introduction. The incidence of metabolic disorders in obese people is not only determined by the amount of adipose tissue but mainly by its distribution. Metabolic disorders may lead to the development of occupational metabolic diseases. Aim of Study. The aim of the study was to estimate the effects of increased physical activity in women with abdominal obesity on carbohydrate and lipid metabolism and glucose tolerance. Material and Methods. The study was carried out on a group of 32 physically active women aged 59.1 ± 5.39 years. Somatic traits were measured and physiological and biochemical tests (VO2 max, lipid profile, glucose and insulin levels) were carried out at rest while fasting. The BMI, WHR and HOMAIR indices were calculated. Results. The following results were obtained for the sample: BMI (32.9 ± 4.57 kg/m²), WHR (0.88 ± 0.04), VO₂ max (33.6 ± 8.19 ml/kg⁻¹/min⁻¹), total cholesterol (226.3 ± 45.12 mg/dl), LDL-cholesterol (140.6 ± 37.79 mg/dl). Conclusions. The results confirm positive effects of physical activity on the lipid profile and the homeostatic model assessment insulin resistance index (HOMAIR).

Słowa kluczowe

EN

activity effect; physical activity; carbohydrate; lipid; human metabolism; woman; abdominal obesity; obesity

• Wydawca: -
• Czasopismo: Trends in Sport Sciences
• Rocznik: 2013
• Tom: 20
• Numer: 3
• Opis fizyczny: p.153-156,ref.

Twórcy

autor

Kasprzak Z.

• Department of Hygiene, University School of Physical Education, Poznan, Poland

autor

Pilaczynska-Szczesniak L.

• Department of Hygiene, University School of Physical Education, Poznan, Poland

Bibliografia

• 1. Baur L, O'Connor J. Special considerations in childhood and adolescent obesity. Clinics in Dermatology. 2004; 22, 4: 338-344.
• 2. Welle S, Forbes G, Statt M. Energy expenditure under free living conditions in normal weight and overweight woman. Am J Clin Nutr. 1992; 55: 14-21.
• 3. Savage D, Tan G, Acerini C, Jebb S, Agostini M, Gurnell M, Williams R, Umpleby A, Thomas E, Bell J, Dixon A, Dunne F, Bolani R, Cianti S, Vidal-Puig A, Karpe F, Chatterjee V, O'Rahilly S. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-y. Diabetes. 2003; 52, 910-917.
• 4. Prineas R, Folsom A, Kaye S. Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol. 1993; 3, 35-41.
• 5. Astrand PO, Rhyming I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during submaximal work. J Appl Physiol. 1954; 9, 2-8.
• 6. Bobilewicz D. Metody rozdziału frakcji lipoproteinowych (Methodology of lipoprotein fractionation). Cormay- Diagnostyka. 1961; 1, 4-5.
• 7. Mathews D, Hosker J, Rudensky A, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985; 28, 412-419.
• 8. Schluter JM, Fitts RH. Shortening velocity and ATP-ase activity of rat skeletal muscle fibres: effect of endurance training. Am J Physiol. 1994; 266, 1699-1713.
• 9. Swift D, Earnest C, Katzmarzyk P. The effect of different doses of aerobic exercise training on exercise blood pressure in overweight and obese postmenopausal women. Menopause. 2012; 19 (5), 503-509.
• 10. Alberti G, Zimmet P, Shaw J. et al. International Diabetes Federation 2006: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/ docs/IDF_Meta_def_final.pdf (18.04.2013).
• 11. Inoue T, Uchida T, Kamishirado H, et al. Clinical significance of antibody against oxidized low density lipoprotein in patients with arteriosclerotic coronary artery disease. J Am Coll Cardiol. 2001; 37, 555-559.
• 12. Iskra M, Pioruńska-Stolzman M. Przeciwutleniające właściwości lipoprotein o wysokiej gęstości i ich zmiana w reakcji ostrej fazy (Antioxidant properties of lipoproteins of high density and their changes in the acute-phase reaction). Czyn Ryz. 2001; 3-4, 11-18.
• 13. Jeppesen J, Hein H, Suadicani P, et al. Triglycerides concentration and ischemic heart disease. An eight-year follow up in the Copenhagen Male Study. Circulation. 1998; 97, 1029-1036.
• 14. Wallace T, Levy J, Matthews D. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6), 1484-1495.
• 15. McGee SL, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms. Clin Exp Pharmacol Physiol. 2006; 33, 395-399.
• 16. Couillard Ch, Despres J-P, Lamarche B, Bergeron J, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides. Arterioscler Thromb Vasc Biol. 2001; 21, 1226-1232.
• 17. Fujioka S, Matsuzawa Y, Tokunga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987; 36, 54-59.
• 18. Leenen R, Van de Kooy K, Droop A. Visceral fat loss measured by magnetic resonance imaging in relation to changes in serum lipid levels of obese men and women. Arteriosclerosis Tromb. 1993; 13, 438-442.
• 19. Kraus W, Houmard J, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW. Effects of the amount and intensity of exercise on plasma on plasma lipoproteins. N Engl J Med. 2002; 347, 1483-1492.
• 20. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002; 51, 1005-1015.
• 21. Gaziano JM, Hennekens CH, O'Donnell CA, Breslow JL, Buring JE. Fasting triglicerides, high density lipoprotein and risk of myocardial infarction. Circulation. 1997; 96, 2520-2525.
• 22. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24, 4, 683-689.